Personal neoantigen vaccine prompts strong anti-tumor response in patients, study shows

(Dana-Farber Cancer Institute) A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news